[Clinicopathological and molecular features of SMARCA4-deficient carcinoma of the intestinal tract].

Huang, R F; He, C; Zhu, W F; Shi, Y; Chen, X Y; Lu, J P; Chen, G

Huang, R F; He, C; Zhu, W F; Shi, Y; Chen, X Y; Lu, J P; Chen, G.

Afiliação

Huang RF; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
He C; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Zhu WF; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Shi Y; Department of Molecular Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Chen XY; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Lu JP; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Chen G; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.

Zhonghua Bing Li Xue Za Zhi ; 50(4): 382-384, 2021 Apr 08.

Article em Zh | MEDLINE | ID: mdl-33831999

Assuntos

Carcinoma; Biomarcadores Tumorais; DNA Helicases/genética; Humanos; Proteínas Nucleares/genética; Fatores de Transcrição/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Limite: Humans Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google